Literature DB >> 15073604

Diffuse large B-cell lymphomas with germinal center B-cell-like differentiation immunophenotypic profile are associated with high apoptotic index, high expression of the proapoptotic proteins bax, bak and bid and low expression of the antiapoptotic protein bcl-xl.

Maria Bai1, Angelos Skyrlas, Niki John Agnantis, Sevasti Kamina, Elena Tsanou, Constantina Grepi, Vassiliki Galani, Panagiotis Kanavaros.   

Abstract

The aim of this study was to analyze the relations between differentiation immunophenotypes and the status of apoptosis and proliferation in diffuse large B-cell lymphomas. Therefore, the bcl6/CD10/MUM1/CD138 differentiation immunophenotypic profiles were studied in relation to (a) the apoptotic index, (b) the apoptosis-associated bcl2 family proteins bcl2, bcl-xl, bax, bak, bad and bid, (c) the proliferation index (Ki67) and (d) the cell cycle proteins cyclin A, cyclin B1, cyclin D3, cyclin E, p53, Rb, p16 and p27 in 79 cases of diffuse large B-cell lymphomas. Two major differentiation immunophenotypic profiles were distinguished: the germinal center B-cell-like profile; 31 cases (bcl6+/CD10+/-/MUM1-/CD138-: 29 cases and bcl6-/CD10+/MUM1-/CD138-: two cases) and the nongerminal center B-cell-like profile (bcl6+/-/CD10-/MUM1+/CD138-); 48 cases. The expression of bax, bak and bid and the apoptotic index were significantly higher in the germinal center B-cell-like profile than in the nongerminal center B-cell-like profile (P=0.045, 0.018, 0.003 and 0.034, respectively). In contrast, the expression of bcl-xl was significantly lower in the germinal center B-cell-like profile than in the nongerminal center B-cell-like profile (P=0.026). The expression of bcl6 and CD10 showed significant positive correlation with the expression of bax (r=0.659, P<0.001 and r=0.240, P=0.033, respectively), bak (r=0.391, P<0.001 and r=0.233, P=0.039, respectively) and bid (r=0.652, P<0.001 and r=0.238, P=0.035, respectively) and significant negative correlation with the expression of bcl-xl (r=-0.536, P<0.001 and r=-0.250, P=0.029, respectively). The expression of MUM1 showed significant negative correlation with the expression of bax (r=-0.276, P=0.014) and bid (r=-0.266, P=0.018) and significant positive correlation with the expression of bcl-xl (r=0.238, P=0.037). The above findings indicate that diffuse large B-cell lymphomas with germinal center B-cell-like immunophenotypic profile are associated with increased apoptosis status, high expression of the proapoptotic proteins bax, bak and bid and low expression of the antiapoptotic protein bcl-xl. Copyright 2004 USCAP, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15073604     DOI: 10.1038/modpathol.3800130

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  12 in total

Review 1.  Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms.

Authors:  Alexandra Papoudou-Bai; Eleftheria Hatzimichael; Alexandra Barbouti; Panagiotis Kanavaros
Journal:  Clin Exp Med       Date:  2016-09-06       Impact factor: 3.984

Review 2.  Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue.

Authors:  Dimitrios Kalogeropoulos; Alexandra Papoudou-Bai; Panagiotis Kanavaros; Chris Kalogeropoulos
Journal:  Clin Exp Med       Date:  2017-09-22       Impact factor: 3.984

3.  Cutaneous vasculitis as an initiating paraneoplastic symptom in Hodgkin lymphoma.

Authors:  Zsófia Simon; Tünde Tarr; László Tóth; Gabriella Szucs; Arpád Illés
Journal:  Rheumatol Int       Date:  2007-12-19       Impact factor: 2.631

4.  R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphoma.

Authors:  Xiao-Hui He; Bo Li; Sheng Yang; Ning Lu; Xun Zhang; Shuang-Mei Zou; Ye-Xiong Li; Yong-Wen Song; Shan Zheng; Mei Dong; Sheng-Yu Zhou; Jian-Liang Yang; Peng Liu; Chang-Gong Zhang; Yan Qin; Feng-Yi Feng; Yuan-Kai Shi
Journal:  Chin J Cancer       Date:  2012-05-23

5.  Bcl-xL is an oncogenic driver in colorectal cancer.

Authors:  Anna-Lena Scherr; Georg Gdynia; Mariam Salou; Praveen Radhakrishnan; Katarina Duglova; Anette Heller; Sophia Keim; Nicole Kautz; Adam Jassowicz; Christin Elssner; You-Wen He; Dirk Jaeger; Mathias Heikenwalder; Martin Schneider; Achim Weber; Wilfried Roth; Henning Schulze-Bergkamen; Bruno Christian Koehler
Journal:  Cell Death Dis       Date:  2016-08-18       Impact factor: 8.469

6.  Expression IRF/MUM1>25% Predictor to Three-year Survival of Diffuse Large B Cell Lymphoma in the Immunochemotherapy Era.

Authors:  Alma Sofo-Hafizovic; Adisa Chikha; Refet Gojak; Emina Suljovic Hadzimesic
Journal:  Med Arch       Date:  2016-10-25

7.  Long Non-Coding RNAs Modulate Sjögren's Syndrome Associated Gene Expression and Are Involved in the Pathogenesis of the Disease.

Authors:  Marzia Dolcino; Elisa Tinazzi; Claudio Vitali; Nicoletta Del Papa; Antonio Puccetti; Claudio Lunardi
Journal:  J Clin Med       Date:  2019-09-01       Impact factor: 4.241

8.  FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma.

Authors:  Linka Xie; Olga Ritz; Frank Leithäuser; Hanfeng Guan; Johanna Färbinger; Clarissa D Weitzer; Franziska Gehringer; Silke Bruederlein; Karlheinz Holzmann; Marion J Vogel; Peter Möller; Thomas Wirth; Alexey Ushmorov
Journal:  Oncotarget       Date:  2014-07-30

9.  miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies.

Authors:  Sayer Al-Harbi; Gaurav S Choudhary; Jey Sabith Ebron; Brian T Hill; Nagarajavel Vivekanathan; Angela H Ting; Tomas Radivoyevitch; Mitchell R Smith; Girish C Shukla; Alex Almasan
Journal:  Mol Cancer       Date:  2015-11-04       Impact factor: 27.401

10.  Molecular Subtypes, Apoptosis and Proliferation Status in Indonesian Diffuse Large B-Cell Lymphoma Cases

Authors:  Yosinta Snak; Kartika Widayati; Nur Arfian; Nungki Anggorowati
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.